Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
313.97-0.56 (-0.18%)
As of 10:20 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close314.53
Bid313.78 x 200
Ask314.11 x 100
Day's Range313.12 - 315.99
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap68.8B
P/E Ratio (ttm)18.34
Avg Vol (3m)1,772,740
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube41 minutes ago

    ETF’s with exposure to Biogen, Inc. : September 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Biogen, Inc. Here are 5 ETF’s with the largest exposure to BIIB-US. Comparing the performance and risk of Biogen, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire3 hours ago

    Anavex Compound to be Tested in Biogen Neurological Protection Model

    NEW YORK, Sept. 28, 2016-- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...

  • Ionis/Biogen Complete Nusinersen NDA Submission in U.S.

    Ionis/Biogen Complete Nusinersen NDA Submission in U.S.

    Ionis' (IONS) partner, Biogen (BIIB) has completed the rolling submission of an NDA for nusinersen for the treatment of spinal muscular atrophy.